Anzeige
Mehr »
Login
Samstag, 27.07.2024 Börsentäglich über 12.000 News von 684 internationalen Medien
BRANDNEUE Gold-Entdeckung: OMEGA stößt auf HOCHGRAD-Gold! 18,98 m @ 6,22 g/t Gold! TA-Preis "STARKER-KAUF"
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JWL4 | ISIN: NO0010598683 | Ticker-Symbol: HBQ
Frankfurt
26.07.24
09:28 Uhr
0,160 Euro
-0,007
-3,90 %
1-Jahres-Chart
HOFSETH BIOCARE ASA Chart 1 Jahr
5-Tage-Chart
HOFSETH BIOCARE ASA 5-Tage-Chart
RealtimeGeldBriefZeit
0,1670,17326.07.

Aktuelle News zur HOFSETH BIOCARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.07.Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.79Ålesund, 02.07.24, Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine lipid and peptide research, today announces the decision to transfer its eosinophil-targeting drug candidate...
► Artikel lesen
11.06.Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY2
16.05.Hofseth Biocare ASA: First Quarter 2024 Financial Report141The first quarter of 2024 continued on the positive trend for HBC. Sales revenues came in at NOK 52m vs NOK 44m last year, a growth of 17 % YoY. The underlying growth we are seeing is coming from both...
► Artikel lesen
10.05.Hofseth Biocare ASA: Annual General Meeting completed2
19.04.Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 20242
19.04.Hofseth Biocare ASA: HBC ANNUAL REPORT 20232
08.04.Hofseth BioCare ASA: NOTIFICATION OF MAJOR HOLDINGS4
05.04.Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING5
21.03.Hofseth Biocare ASA: UPDATED COMPANY PRESENTATION-
14.03.Hofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWN3
09.02.Hofseth Biocare ASA: Fourth Quarter 2023 And Full Year Financial Report268HBC had gross operating revenues of NOK 47.4m (33.6m) in the fourth quarter and NOK 218.5m (120.4m) for the full year. Adjusted for the sale of assets in the second quarter, operating revenues were...
► Artikel lesen
06.02.Hofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal therapy demonstrating significant anti-tumour activity1
10.11.23Hofseth Biocare ASA: Hofseth Biocare Asa: Third Quarter 2023 Financial Report272The third quarter of 2023 shows a significant growth of forty percent in sales compared to the same period last year and the increase in margins in Q2 continues. Sales revenues ended at NOK 49.9m...
► Artikel lesen
25.08.23Hofseth Biocare ASA: Second Quarter 2023 Financial Report364The second quarter of 2023 shows a 100 % growth in sales compared to the same period last year and strong increase in margins. Sales revenues ended at NOK 52.9m vs NOK 25.8m last year. The underlying...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1